VEGFA and cancer: Myeloid cells including myeloid-derived suppressor cells in tumors has been implicated in suppression of antitumor immunity [47], and VEGF/VEGF receptor blockade has been shown to reduce myeloid-derived suppressor cells in tumors and blood in preclinical tumor models and human cancers [18].